SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

Similar documents
SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

MRC-Holland MLPA. Description version 08; 30 March 2015

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

MRC-Holland MLPA. Description version 14; 28 September 2016

MRC-Holland MLPA. Description version 12; 13 January 2017

MRC-Holland MLPA. Description version 07; 26 November 2015

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 18; 09 September 2015

MRC-Holland MLPA. Description version 08; 18 November 2016

MRC-Holland MLPA. Description version 08; 07 May 2015

SALSA MLPA probemix P315-B1 EGFR

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

P323-B1 CDK4-HMGA2-MDM2

MRC-Holland MLPA. Description version 06; 23 December 2016

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

SALSA MLPA KIT P050-B2 CAH

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

MRC-Holland MLPA. Description version 06; 07 August 2015

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 19;

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

MRC-Holland MLPA. Description version 13;

SALSA MLPA KIT P060-B2 SMA

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

MRC-Holland MLPA. Description version 52; 22 July 2015

PRADER WILLI/ANGELMAN

MRC-Holland MLPA. Description version 23; 15 February 2018

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 28; 4 January 2018

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

MRC-Holland MLPA. Description version 10; 06 April 2018

MRC-Holland MLPA. Description version 23; 26 January 2017

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

Maturity-onset diabetes of the young (MODY) is a heterogeneous group

MRC-Holland MLPA. Description version 15;

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Diagnosis of monogenic diabetes: 10-Year experience in a large multi-ethnic diabetes center

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

The Human Major Histocompatibility Complex

Sharan Goobie, MD, MSc, FRCPC

UKGTN Testing Criteria

Certificate of Analysis

MRC-Holland MLPA. Description version 24;

This is DUE: Come prepared to share your findings with your group.

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Analysis with SureCall 2.1

Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4)

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Chapter 1 : Genetics 101

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Role of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Corporate Medical Policy

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

For in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.

Screening of mutations in the GCK gene in Jordanian maturity-onset diabetes of the young type 2 (MODY2) patients

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Muscular Dystrophy. Biol 405 Molecular Medicine

CHROMOSOMAL MICROARRAY (CGH+SNP)

Structural Variation and Medical Genomics

Issues arising from UKNEQAS schemes. Ottie O Brien, Northern Genetics Service, Newcastle, UK 15 th May 2014

Reporting TP53 gene analysis results in CLL

Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Exosome DNA Extraction Kits

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

(SMN1), which is found in the lower part of the spinal cord. 1 There are several different types of

Lynch Syndrome and COLARIS Testing

STRUCTURAL CHROMOSOMAL ABERRATIONS

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Molecular Characterization of the NF2 Gene in Korean Patients with Neurofibromatosis Type 2: A Report of Four Novel Mutations

Detection of copy number variations in PCR-enriched targeted sequencing data

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Human Chromosomes. Lesson Overview. Lesson Overview Human Chromosomes

Role of next generation sequencing in clinical care

Transcription:

mix P241-D2 MODY mix 1 Lot D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent diabetes mellitus (NDDM), also known as type II diabetes. MODY has a clear autosomal inheritance and it generally develops in individuals under age of 25 years. Approximately 5% of all diabetes patients suffer from MODY. As described in more detail on page 2, eleven forms of MODY are identified with the highest prevalence for MODY 2 and 3. Each form of MODY is associated with one gene. This P241-D2 MODY mix contains s for the GCK, HNF1A, HNF1B and HNF4A genes and is therefore specific for MODY 1, 2, 3 and 5. A total of 42 s are present for these four genes. In addition, 8 reference s are included in this mix, detecting 8 different autosomal chromosomal locations. This SALSA mix is designed to detect deletions/duplications of one or more sequences in the aforementioned genes in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak height of the amplification product of that. Note that a mutation or polymorphism in the sequence detected by a can also cause a reduction in relative peak height, even when not located exactly on the ligation site! In addition, some signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. We have no information on what percentage of defects in these genes is caused by deletions/duplications of complete exons. Finally, note that most defects in these genes are expected to be small (point) mutations which will not be detected by this SALSA test. SALSA mixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the test mixes and reagents includes a limited license to use these products for research purposes. The use of a SALSA mix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). Related SALSA mixes P117 ABCC8: Contains s for the ABCC8 gene, involved in familial hyperinsulinemic hypoglycemia 1. P357 MODY mix 2: Contains s for PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4 and INS genes, involved in MODY 4 to 10. References for SALSA mix P241 MODY mix 1 Valentínová L. et al., 2012. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia. PLOS One 7: e34541. Carette C. et al., 2010. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med. 27:1454-8. Gasperíková D. et al., 2009. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (- 71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans. Diabetes 58:1929-35. Garin I. et al., 2008. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. Clin Endocrinol. 68:873-8. More information Website : www.mlpa.com E-mail : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 1, 1057 DL Amsterdam, the Netherlands SALSA P241 MODY mix 1 mix Page 1 of 7

The MODY genes MODY 1 is a result of defects in the Hepatocyte nuclear factor-4-alpha (HNF4A) gene on chromosome 20q13. The HNF4A gene comprises 11 exons and spans about 30 kb of genomic DNA. The protein encoded by this gene regulates the expression of HNF1A. MODY 2 is caused by mutations in the Glucokinase gene (GCK) on chromosome 7p13. This gene comprises 12 exons, spans about 45 kb of genomic DNA. MODY 3 is caused by defects in the HNF1 Homeobox A gene (HNF1A) on chromosome 12q24, which comprises 10 exons and spans about 24 kb of genomic DNA. MODY 4 has been linked to defects in the Pancreas/Duodenum homeobox protein 1 gene (PDX1) on chromosome 13q12.1. This gene comprises 2 exons and spans about 6 kb of genomic DNA. (Probemix P357) MODY 5 (RCAD) have been associated with the HNF1 Homeobox B gene (HNF1B) on chromosome 17q12. The HNF1B gene comprises 9 exons and spans about 59 kb of genomic DNA. MODY 6 has been linked to defects in the NEUROD1 gene on 2q31. This gene, with a size of 4 kb, has 2 exons. (Probemix P357) MODY 7 is caused by mutations in the Kruppel-Like Factor 11 gene (KLF11) on chromosome 2p25.1. It consists of 4 exons and spans approximately 11 kb of genomic DNA. (Probemix P357) MODY 8 has been associated with defects in Carboxyl-ester lipase gene (CEL) on chromosome 9q34, which has a size of 10 kb and has 11 exons. (Probemix P357) MODY 9 is caused by defects in the Paired box 4 gene (PAX4) on chromosome 7q32. This gene spans 5.4 kb of genomic DNA, contains 9 exons. (Probemix P357) MODY 10 has been linked to mutations in the insulin gene (INS) on chromosome 11p15. This gene has 3 exons and has a size of 1.4 kb. (Probemix P357) MODY 11 has been linked to defects in the B lymphoid tyrosine kinase gene (BLK). BLK is comprised of 13 exons spanning about 70 kb. No s for this gene have been included in P241 or P357. Data analysis The P241-D2 MODY mix contains 50 MLPA s with amplification products between 130 and 495 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at 64-70-76-82 nt, three DNA Denaturation control fragments (Dfragments) at 88-92-96 nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this mix can first be normalised intra-sample by dividing the peak height of each s amplification product by the total height of only the reference s in this mix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing the intra-normalised ratio in a sample by the average intra-normalised ratio of all reference samples. Please note that this type of normalisation assumes no changes occurred in the genomic regions recognised by the reference s. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website www.mlpa.com. Many copy number alterations in healthy individuals are described in the database of genomic variants: http://dgv.tcag.ca/dgv/app/home. For example, a duplication of a complete gene might not be pathogenic, while a partial duplication or a deletion may result in disease. For some genes, certain in-frame deletions may result in a very mild, or no disease. Copy number changes of reference s are unlikely to be the cause of the condition tested for. Users should always verify the latest scientific literature when interpreting their findings. This mix was developed by. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA P241 MODY mix 1 mix Page 2 of 7

Table 1. P241-D2 MODY mix 1 mix Chromosomal position reference GCK HNF1A HNF1B HNF4A 64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 130 Reference 00797-L13645 5q31 136 HNF1B 09858-L21367 7 142 GCK 07721-L07431 2 (4) 147 HNF1A 07710-L07442 2 154 HNF4A 07734-L07424 8 (7) 160 HNF1B 07699-L07458 2 166 GCK 07724-L07434 5 (7) 172 HNF1A 07718-L07450 10 178 ± GCK 07729-L07439 10 (12) 184 HNF1A 07711-L07443 3 189 «Reference 06054-L21306 1p36 196 HNF1A 07715-L07447 7 202 HNF1B 08298-L09334 8 208 HNF4A 09853-L10275 9 (8) 214 HNF4A 07733-L07423 6 (5) 220 GCK 07720-L07430 1 226 HNF1A 07708-L07440 1 232 GCK 07728-L07438 9 (11) 238 HNF1B 16906-L19835 5 244 * Reference 13389-L14846 6q12 251 HNF1A 07717-L07449 9 259 HNF4A 16914-L21368 12 (11) 265 GCK 07723-L21369 4 (6) 274 Reference 14110-L21370 8p21 280 HNF1A 16907-L21371 4 286 HNF4A 07737-L21372 11 (10) 294 GCK 07726-L21373 7 (9) 301 HNF1B 16908-L19837 4 310 Reference 14480-L16200 4q12 319 HNF4A 07731-L07421 4 (3) 326 HNF1A 16752-L20209 1 337 GCK 07722-L07432 3 (5) 346 HNF1A 09856-L11390 8 355 HNF4A 07736-L07426 10 (9) 364 HNF1B 07701-L07460 4 371 Reference 05770-L21374 16q11 378 GCK 07727-L21375 8 (10) 386 HNF1B 16909-L21376 3 393 HNF4A 07732-L21377 5 (4) 400 ๑ HNF4A 09852-L11391 3 (2) 409 HNF4A 09999-L21378 7 (6) 418 HNF1A 07713-L07445 5 423 GCK 07719-L07429 1 436 HNF1B 16910-L19839 9 445 Reference 14670-L16322 19q13 454 GCK 07725-L07435 6 (8) 463 HNF1B 07704-L07463 6 472 HNF1A 16913-L12292 6 484 HNF1B 16912-L18619 1 495 Reference 12462-L17153 22q12 * New in version D2 (from lot D2-0413 onwards). «This is located within, or close to, a very strong CpG island. A low signal of this can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. SALSA P241 MODY mix 1 mix Page 3 of 7

๑ The significance of exon 3 deletions is not clear as this exon is not present in the MODY1 associated transcript variant 5 NM_175914.4. ± SNP rs527259972 is reported to influence the signal in two unrelated cases. In case of apparent deletions, it is recommended to sequence the region targeted by this. Notes The exon numbering for the GCK and HNF4A genes has changed. From description 19 onwards, we have adopted the NCBI exon numbering that is present in the Genbank NM_000162.3 sequence for the GCK gene and the Genbank NG_009818.1 sequence for the HNF4A gene. This exon numbering used here may differ from literature! The exon numbering used in previous versions of this product description can be found between brackets in Table 1 and Table 2. The identity of the genes detected by the reference s is available on request: info@mlpa.com. Table 2. P241 s arranged according to chromosomal location Table 2a. GCK gene GCK NM_000162.3 next start codon 471-473 (ex 1) 423 07719-L07429 1 54-55 GCTAGGATGTGA-GAGACACAGTCA 0.4 kb 220 07720-L07430 1 492-493 ACAGAGCCAGGA-TGGAGGCCGCCA 35.5 kb 142 07721-L07431 2 (4) 584-585 AGACGGATGCAG-AAGGAGATGGAC 1.0 kb 337 07722-L07432 3 (5) 717-718 TGGGTGGCACTA-ACTTCAGGGTGA 1.4 kb 265 07723-L21369 4 (6) 889-890 GCATCAGATGAA-ACACAAGAAGCT 0.2 kb 166 07724-L07434 5 (7) 1008-1009 CAGAAGGGAACA-ATGTCGTGGGGC 1.0 kb 454 07725-L07435 6 (8) 1119-1120 GCTACTACGAAG-ACCATCAGTGCG 2.1 kb 294 07726-L21373 7 (9) 1288-1287 reverse CCAGGCGGTCAT-ACTCCAGCAGGA 1.1 kb 378 07727-L21375 8 (10) 1359-1360 TAGGTGGCAAGT-ACATGGGCGAGC 0.9 kb 232 07728-L07438 9 (11) 1525-1526 CTACAACATCCT-GAGCACGCTGGG 0.9 kb 178 ± 07729-L07439 10 (12) 2163-2164 TCACTCAGGACT-TTGATGCATTTC stop codon 1866-1868 (ex 10) ± SNP rs527259972 is reported two influence the signal in two unrelated cases. In case of apparent deletions, it is recommended to sequence the region targeted by this. The NM_000162.3 sequence represents transcript variant 1 and is a reference standard in the NCBI RefSeqGene project. Note: The GCK exon numbering has changed. From description version 19 onwards, we have adopted the NCBI exon numbering that is present in the Genbank NM_000162.3 sequence. The exon numbering used in previous versions of this product description can be found between brackets in Table 1 and Table 2. Table 2b. HNF1A gene HNF1A NM_000545.5 next start codon 24-26 (ex 1) 226 07708-L07440 1 32-33 GCCATGGTTTCT-AAACTGAGCCAG 0.5 kb 326 16752-L20209 1 169 nt after ex 1 CTTGGAGGTTTG-AGCCTCCAGCCC 9.7 kb 147 07710-L07442 2 461-462 CACCTGTCCCAA-CACCTCAACAAG 4.6 kb 184 07711-L07443 3 604-605 AGGTGATGAGCT-ACCAACCAAGAA 0.7 kb 280 16907-L21371 4 845-846 CGGCGCAAAGAA-GAAGCCTTCCGG 2.0 kb 418 07713-L07445 5 1019-1020 GAGACTGCAGAA-GTACCCTCAAGC 0.3 kb 472 16913-L12292 6 1196-1197 AGCTTGGAGCAG-ACATCCCCAGGC 1.0 kb 196 07715-L07447 7 1453-1452 reverse GCACAGGTGGCA-TGAGCGGCTGCT 1.7 kb 346 09856-L11390 8 1539-1538 reverse CACCTCGGGCTT-GTGGCTGTAGAG 0.2 kb 251 07717-L07449 9 1658-1657 reverse GCCTCAGTGTCT-GAGGTGAAGACC 1.6 kb 172 07718-L07450 10 1807-1808 CTCCAGCAGCCT-GGTGCTGTACCA stop codon 1917-1919 (ex 10) The NM_000545.5 sequence is a reference standard in the NCBI RefSeqGene project. SALSA P241 MODY mix 1 mix Page 4 of 7

Table 2c. HNF1B gene HNF1B NM_ 000458.3 next start codon 195-197 (ex 1) 484 16912-L18619 1 199-200 TTGGAAAATGGT-GTCCAAGCTCAC 5.3 kb 160 07699-L07458 2 591-592 TGCAGCAACACA-ACATCCCCCAGA 5.9 kb 386 16909-L21376 3 876-877 CTGAGCCCACCA-ACAAGAAGATGC 0.2 kb 364 07701-L07460 4 1070-1069 reverse ACACGGACCTCA-GTGACCAAGTTG 1.9 kb 301 16908-L19837 4 1231-1230 reverse TACCTGACAGCT-TGTTTGGAGGAG 21.1 kb 238 16906-L19835 5 20 nt after ex 5 reverse CTCCAGAGCGAC-AATGGCCCAGGT 5.5 kb 463 07704-L07463 6 1418-1419 GTCTCAGGAGGA-GGTTTGCCCCCA 4.0 kb 136 09858-L21367 7 1653-1652 reverse GCTCTGCTGCAT-GAGGGGCTGCTG 2.0 kb 202 08298-L09334 8 1817-1818 AGCAGCATCAGT-ACACTCACCAAC 11.9 kb 436 16910-L19839 9 2007-2006 reverse GAGGTGCCAGCA-GGACGTCCGTCA stop codon 1866-1868 (ex 9) The NM_000458.3 sequence represents variant 1 and is a reference standard in the NCBI RefSeqGene project. Table 2d. HNF4A gene HNF4A NM_175914.4 start codon 5-7 (ex 1) No 1 No 2 78 nt after ex 3 (NM_000457.4) 400 ๑ 09852-L11391 3 (2) CTTTGGCACTCA-ACTTTGGGGTGG next SALSA P241 MODY mix 1 mix Page 5 of 7 4.5 kb 319 07731-L07421 4 (3) 77-78 CAGAAGGCACCA-ACCTCAACGCGC 1.4 kb 393 07732-L21377 5 (4) 292-293 TGCAGGCTCAAG-AAATGCTTCCGG 6.1 kb 214 07733-L07423 6 (5) 162 nt before ex 6 reverse AACTCAGCTGGT-GGAAGAACTTTC 1.1 kb 409 09999-L21378 7 (6) 519-520 CATGAAGGAGCA-GCTGCTGGTTCT 3.8 kb 154 07734-L07424 8 (7) 5 nt before ex 8 TTCCTTCTCTCT-TTCAGGTGGCCC 1.5 kb 208 09853-L10275 9 (8) 66 nt after ex 9 reverse TACAGAACCCAA-TAGGAGAAGTCT 4.3 kb 355 07736-L07426 10 (9) 1007-1008 AGCAGATCCAGT-TCATCAAGCTCT 4.3 kb 286 07737-L21372 11 (10) 19 nt after ex 11 AACTCTGGGATT-TTACCTTGCAAA 2.2 kb 259 16914-L21368 12 (11) 2383-2384 CTGAGGTCCTGA-TCAGCTTCAAGG stop codon 1361-1363 (ex 10) ๑ The significance of exon 3 deletions is not clear as this exon is not present in the MODY1 associated transcript variant 5 NM_175914.4. The NM_175914.4 and NM_000457.4 sequences represent transcript variants 5 and 2, respectively. Both sequences are reference standards in the NCBI RefSeqGene project. Notes The HNF4A exon numbering has changed. From description version 19 onwards, we have adopted the NCBI exon numbering from the Genbank NG_009818.1 sequence. The exon numbering used in previous versions of this product description can be found between brackets in Table 1 and Table 2. The HNF4A transcript variant has changed. From description version 20 onwards, we have indicated the ligation sites for the majority of the HNF4A s according to the NM_175914.4 sequence. NM_175914.4 encodes the MODY1 associated isoform HNF4alpha8 (Carette et al. 2010). Compared to transcript variant 2, it contains an alternative first exon and translation initiation site. 2 and exon 3 are not present in the NM_175914.4 sequence. 1 and exon 2 are not present in the NM_000457.4 sequence. Mutations/deletions in exon 1 of the HNF4A gene are known to cause MODY (Colclough et al. 2013, Hum Mutat. 34:669-685). Please note that copy number changes of HNF4A exon 1 cannot be detected by this mix, as there are no MLPA s included for HNF4A exon 1.

Note: numbering used here may differ from literature! Complete sequences are available on request: info@mlpa.com. Please notify us of any mistakes: info@mlpa.com. mix P241-D2 MODY sample picture Figure. Capillary electrophoresis pattern of a sample of approximately 50 ng human male control DNA analysed with mix P241-D2 MODY (lot D2-0413). Implemented Changes compared to the previous product description versions. Version 20 (55) 08 April 2016 - Information added about transcript NM_175914.4 of the HNF4A gene. - s in Table 2d adjusted according to the NM_175914.4 sequence. - Probe remarks added in Table 1 and Table 2; 178 nt 07729-L07439, 189 nt 06054-L21306 and 400 nt 09852-L11391. - Various minor textual and layout changes. Version 19 (54) 15 July 2015 - numbering for the GCK and HNF4A genes has changed in Table 1 and 2. - s for HNF1B has been changed in Table 2c. Version 18 (54) 04 March 2015 - New sample picture included in product description. Version 17 (53) - RCAD is added as synonym of MODY5 - Corrected text on data analysis. - Updated link for Database of Genomic Variants. Version 16 (50) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). Version 15 (48) - Partial sequences of the GCK exon 1 s have been corrected. These had been switched in previous versions. Version 14 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. SALSA P241 MODY mix 1 mix Page 6 of 7

Version 13 (47) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). - Various minor textual changes on page 1 Version 12 (46) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). Version 11 (45) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). - numbering of the HNF4A and GCK genes has been changed. - s updated according to new version of the NM_reference sequence. - Tables have been numbered. Small changes of lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. - Various minor textual changes on page 1, various minor layout changes. - Data analysis method has been changed. SALSA P241 MODY mix 1 mix Page 7 of 7